Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 18, 2016 8:00 AM - Oct 19, 2016 4:00 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting 2016

Explore how innovation can support new initiatives, regulatory processes, research, transparency, engagement, personalized medicine, and use of real-world data in Canada.

Session 4 Track C: Personalized Medicine

Session Chair(s)

Karen  Feltmate

Karen Feltmate

President

Redstone Health Group, Inc., Canada

Session 4 Track C: Personalized Medicine

Learning Objective : 1) Understand the latest technological advancements in personalized medicine technology 2) Evaluate cost/benefit drivers for patient populations 3) Identify existing approved biomarkers and the implications of biomarker regulatory approval on product commercialization 4) Describe reimbursement considerations for personalized medicine based technologies in the health care arena

Speaker(s)

Laura  Durno, MS, MSc

Session Co-Chair

Laura Durno, MS, MSc

Biologics and Genetic Therapies Directorate, Health Canada, Canada

Acting Chief, Viral Vaccines Division

Stephen F. Amato, PhD, RAC

The Keys to a Successful Personalized Medicine Strategy

Stephen F. Amato, PhD, RAC

Cardinal Health Regulatory Sciences, United States

Managing Director of East Coast Operations

George  Wyatt

Speaker

George Wyatt

Wyatt Health Management, Canada

Managing Director

Katherine M. Soltys, MD

Speaker

Katherine M. Soltys, MD

Health Canada, Canada

Director, Office of Clinical Trials, Pharmaceutical Drug Directorate

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.